Delivery Order SPE2DB20D3101-SPE2DB23FRVF1
- Not listed
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablet, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,964.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has an ultimate completion date of May 11, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $76,499.29 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award has a completion date of February 23, 2023 and was not set aside for any specific business designation. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for various federal healthcare programs, particularly...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $7,633.73 firm-fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of November 7, 2023 and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $7,548.53 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, which is a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 6, 2021 and was awarded on August 5, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablet, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $51,915.00 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed price, delivery order type, without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablet, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $39,380.91 delivery order contract with Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a firm fixed-price agreement with a period of performance through December 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $62,527.11 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,740.22 and is a firm fixed-price delivery order. There is no set-aside designation, indicating the contract was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract has a ceiling value of $10,728.19 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of March 7, 2024. There is no set-aside designation for this contract....
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $68,980.32 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of September 19, 2023 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, which...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRVF1Delivery Order
This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $4,759.11 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of August 18, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC, allowing the DLA to efficiently procure essential medications for military and veteran beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/17/23 |